Published Date: 20-Aug-2020
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Mobile Cardiac Telemetry Systems Market, published by KBV research, The Global Mobile Cardiac Telemetry Systems Market size is expected to reach $1.4 billion by 2026, rising at a market growth of 11.3% CAGR during the forecast period.
The lead-based segment accounted for the largest dominant revenue share in the mobile cardiac telemetry systems market as lead-based MCTs are light weighted, user-friendly, and therefore preferred among several patients. The patch-based segment is anticipated to witness lucrative growth over the forecast period. Patch-based Continuous Cardiac Rhythm Monitoring (CCRM) has emerged as a useful clinical tool for the quantification and surveillance of bradyarrhythmia and tachyarrhythmia in outpatient settings.
The hospital segment dominated the market with a substantial market share. The growth of this segment can be associated with a rise in the amount of minimally invasive surgeries in these facilities. The Cardiac Center segment is predicted to see the fastest growth in the projected period. Growth is mainly attributed to an increase in the number of cardiac centers and the easy availability of surgeons within these facilities.
North America dominated the market for mobile cardiac telemetry. This growth is attributable to multiple factors like the increasing geriatric population, the prevalence of cardiac disorders, and rising healthcare costs. The Asia Pacific is expected to show lucrative growth over the forecast period. Factors such as dietary habits and the increasing adoption of sedentary lifestyles leading to physical inactivity contribute to increased cardiovascular morbidity in the region.
Structural Insights: https://www.kbvresearch.com/mobile-cardiac-telemetry-systems-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Hill-Rom Holdings, Inc. (Welch Allyn), Asahi Kasei Corporation (Zoll Medical Corporation), ScottCare Corporation (Berkshire Hathway, Inc.), iRhythm Technologies, Inc., Biotricity, Inc., G Medical Innovations Holdings Ltd. (Telerhythmics LLC), BioTelemetry, Inc., Applied Cardiac Systems, Inc., Medicomp, Inc., and Preventice Solutions, Inc.
Unique Offerings from KBV Research